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Background: This study explored the value of providing information in a Fact Sheet to correct misperceptions
about the relative harmfulness of nicotine replacement products (NRT) and smokeless tobacco (ST), when
compared to cigarette smoking.
Methods: Four convenience samples from different countries (Australia, UK, Sweden and USA) were surveyed
concerning their beliefs about the relative harmfulness of smokeless tobacco and NRT. Study participants were
given the Fact Sheet that explained that nicotine, as used by consumers, is not particularly harmful and explained
why. They were resurveyed one week later regarding their beliefs about the relative harmfulness of smokeless
tobacco and NRT and future intentions to use the products.
Results: In all four samples knowledge increased by similar amounts and beliefs regarding the lower harmfulness
of smokeless tobacco increased. However, misconceptions remained common and responses to belief measures
were not always consistent. Likelihood of use of ST increased in all four samples after exposure to the Fact Sheet,
but interest in NRT use only increased in the US sample.
Conclusions: A Fact Sheet such as this one can help address misconceptions about NRT and smokeless tobacco, at
least in the short term. However, as is true of most educational interventions, exposure to a single educational
session is not sufficient to overcome misperceptions that smokers have about the relative harmfulness of oral
versus combustible forms of nicotine delivery.Background
The majority of harm from tobacco use comes from
combusted forms; that is, from the dirty delivery system,
not the nicotine. Some forms of smokeless tobacco (ST)
are less harmful than others [1,2], with some existing
smokeless products still very harmful (albeit less harmful
than smoking) such as oral tobacco products used in
South Asia and Sudan [3]. This is because they contain
high levels of toxicants, often produced during the
manufacturing, curing and storage process. However,* Correspondence: Ron.Borland@cancervic.org.au
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reproduction in any medium, provided the orwhere concerted efforts have been made to minimize the
levels of known carcinogens and toxicants (most notably
with Swedish snus), the potential harms can be reduced
dramatically compared to cigarettes and made similar to
that of oral nicotine medications, such as gum or loz-
enge. Cleaner forms of smokeless tobacco have been
estimated to be 90–95% less harmful than cigarettes
when used long term [4], and some contend they may
be even less harmful [5]. Recent research syntheses sug-
gest that the difference in estimates is largely a function
of the attributed risk for heart disease and stroke [6-8],
as it now appears that there is little or no excess cancer
risk [9,10]. If as seems prudent, one assumes the current
epidemiology which suggests an elevated risk of both
heart disease and stroke [6-8], then the lower estimate is
the most plausible. However, if this risk is less or even
negligible for the on-average cleaner products such asl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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more consistent with the smaller estimates of risk.
There is now evidence that ST (in at least some forms
and in some contexts) can contribute to smoking cessa-
tion and is not a pathway to uptake of cigarettes [11-13].
While some report using ST to quit smoking on a short-
term basis, others use it as a longer-term substitute or
for an intermediate period of use before quitting all
nicotine use [11,13-15]. Opponents of marketing smoke-
less tobacco as a harm reduction alternative to cigarette
use argue that partial substitution could sustain longer
term use of combustible tobacco thereby negating any
harm reduction benefit. Also, the concept of promoting
ST as an alternative to smoking could entice non-
tobacco users to start using smoked tobacco. However,
as Kozlowski has argued, the primary responsibility of
health authorities is to ensure that the public is well
informed about the relative harms of alternative nicotine
delivery systems [16].
Medicinal quality nicotine replacement products
(NRT) are the standard by which the cleanest forms of
smokeless tobacco should be compared. Currently most
forms of NRT are engineered to minimize consumer ap-
peal as regulators see this as increasing abuse liability.
This is achieved by avoiding products that allow the
rapid absorption of nicotine, a key factor in their con-
sumer attractiveness [17]. The potential of NRT pro-
ducts for long term use is largely untested, although
some people who use NRT to quit smoking continue to
use it longer term [18]. The limited available evidence is
that use of NRT for up to at least 5 years is safe [19].
Some tobacco control advocates have been arguing for
a strategy of encouraging smokers to move to alternative
forms of nicotine [20]. This is supported by major
reports supporting harm reduction strategies [5,21]. For
a product substitution strategy to be effective, it would
require that tobacco users understand the relative safety
of alternative forms of nicotine, be prepared to try them
as alternatives, and for them to find the products suffi-
ciently attractive to persist in their use, and also stop
using smoked forms.
There is little doubt that in Sweden, the use of ST (in
this case Swedish snus) and, to a lesser extent NRT, have
contributed to a reduction in the prevalence of smoked
tobacco use among men. In Sweden, even with high
levels of long-term ST use, there is a net health benefit
from the reduction in smoked tobacco as evidenced by
the rapid decline in smoking caused deaths [22]. The
National Board of Health and Welfare (Socialstyrelsen)
stated in its National Public Health Report for 2005
(after summarizing recent scientific studies): “Hence
these results indicate that the net effects of using snuff as
a way of stopping smoking can be positive since smoking
is so much more hazardous to health than snuff-taking”[23]. The apparent substitution of ST for cigarettes in
Sweden is remarkable in the context of there having
been no explicit promotion of ST as a less harmful alter-
native to smoking. Research from Sweden [24] shows
low levels of public knowledge about the relative harms
of smoked and smokeless tobacco products, so the
movement to ST in Sweden cannot be thought of as a
movement driven primarily by harm reduction motives.
In this study, only 29% of daily smokers knew that NRT
is a lot less harmful, so there are clearly misconceptions
about NRT as well.
Lack of understanding regarding the relative harm of
smokeless tobacco and NRT compared to cigarettes is
also widespread in other countries [25-27]. In three of
the countries studied here (US, UK and Australia [26])
awareness of the reduced risk of ST is lower than for
NRT, but both are low and held by a minority, except in
the UK where a small majority of smokers accept that
NRT is low harm. These beliefs have remained constant
over most of the 2000s, except in the UK, where they
have increased modestly [26].
In this paper we present the results of a small inter-
vention study intended to explore the effects of provid-
ing factual information on the relative harms of ST/NRT
and smoked tobacco on smokers’ opinions. The Fact
Sheet we produced was designed to provide the kind of
assessment of the relative risks that health authorities
might be persuaded to authorize. We hypothesized that
exposure to the Fact Sheet would increase smokers’
knowledge about the relative harmfulness of ST/NRT
compared to cigarettes and that this in turn would in-
crease receptivity to using ST/NRT as possible substi-
tutes for cigarettes in the future. We also hypothesized
that these findings would be consistent across countries,
despite differences in the use and availability of ST/NRT
products.
Methods
A before-after study design was used to assess changes
in smokers’ understanding of relative harms of nicotine
products attributable to provision of a Fact Sheet sum-
marizing current (at the time it was written) scientific
knowledge on the relative harms of nicotine and smoke-
less tobacco as compared to smoked tobacco.
The Fact Sheet was three A4 pages long: a one page
overview and 2 pages of “Commonly asked questions”
with answers provided. It was provided in pdf form to
download for those completing the study on the inter-
net. In the USA, the Fact Sheet was handed to partici-
pants to read and was augmented by a narrated
Powerpoint presentation of the material. The content
was essentially the same in each country although refer-
ences to country were tailored to the country of use, and
the Swedish version was translated into Swedish by the
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Australia is appended. See Additional file 1).
Participants: We recruited convenience samples of
smokers from four countries using a variety of recruit-
ment techniques (see Table 1). Table 2 provides a de-
scription of the study samples recruited in each country.
Measures
The initial survey contained questions on demographics
and basic information about smoking. Both surveys con-
tained questions on the relative harmfulness of NRT and
ST separately against smoked tobacco (A lot less harm-
ful, A bit less, Similarly harmful, More harmful, Don’t
Know (recoded with Similar for some analyses)). Ques-
tions regarding the likelihood of using NRT on their
next quit attempt, and likelihood of trying ST, were
asked, each with 5 options from very likely to very
unlikely.
Five questions about the mechanisms by which harms
of smoking cigarettes come about were asked and six re-
sponse options (none, a bit, some, a large amount, a very
large amount, and virtually all) were provided for each
question. These questions are: 1) how much do they
think the harm comes from the chemicals that are in the
tobacco before it is burned (with those answered ‘a bit’
or ‘some’ were coded as 1, otherwise coded as 0); 2)
from the chemicals that are created by burning the
tobacco (‘a large amount’ or ‘a very large amount’ were
coded as 1, otherwise 0); 3) from taking the smoke into
the lungs (‘some’, ‘a large amount’ or ‘a very large
amount’ were coded as 1, otherwise 0); 4) do filters re-
move the harmful ingredients in tobacco smoke (‘a bit’
was coded as 1, otherwise 0); and 5) the harm is due to
the nicotine (‘a bit’ was coded as 1, otherwise 0). This
gave a knowledge score of 0–5.
They were also asked about intention to quit (No
intention, Open to the possibility, Thinking of quitting,
but not in the next month, Planning to quit in the next
month, and, I have already quit - follow-up only). At theTable 1 Recruitment methods used in each country
Country Sample size Recruitment of stu
Australia 170 In Australia we initi
(www.quit.org.au). A
were not planning
in a study that invo
second survey. Both
Sweden 187 In Sweden a sampl
from an internet pa
United Kingdom 101 In the UK participan
study on alternative
surveys were used.
United States 59 In the US participan
study on alternative
subjects attended tsecond survey, respondents were also asked how much
of the Fact Sheet they read (None, Skimmed it only,
Read some, Read all), ease of understanding (Very easy,
Fairly easy, Fairly hard, Very hard) and whether they
found the information credible (Totally convinced,
Largely convinced, Uncertain, Not convinced, I think it
was wrong).
Statistical analyses
Paired t tests were used to test for changes in knowledge
and McNemar’s test for changes in the categorical vari-
ables. All analyses were conducted using Stata Version
10.1.
Ethical approval and consent
The Australian study was approved by the Cancer Coun-
cil Victoria’s Human Research Ethics Committee (refer-
ence no. HREC0625), the UK one by Nottingham
Research Ethics Committee 2 (reference no. 07/Q2404/
53), and the US one by the Research Ethics Board of the
Roswell Park Cancer Institute. In Sweden as this was
done as an anonymous web survey, it is exempt from
Ethics requirements. A full review by a research ethics
committee has not been necessary for this type of data
collection according to the rules of the Swedish Law on
Research Ethics Review (2003:400). In all four countries
written informed consent was obtained from the partici-
pants for publication of this report and any accompany-
ing images.
Results
The main findings are summarised in Tables 3 and 4.
Most (around 90% or more) read or at least skimmed
the Fact Sheet. Nearly all (over 95%) found it very or
fairly easy to understand (not in Table), but there was
considerable variation in how convinced they were, with
most retaining a degree of scepticism (Table 3).
As can be seen from Table 4, knowledge of the
mechanisms of tobacco-related harms became moredy sample
ally recruited 391 smokers to a survey on a smoking cessation website
fter the initial survey, smokers of 10+ cigarettes per day who said they
to quit in the next month were told about the possibility of participating
lved trying some alternatives to cigarettes. A total of 170 completed the
surveys were completed on the internet.
e of 213 daily smokers (without specific selection criteria) were recruited
nel and of these 187 completed the second survey.
ts were recruited through advertisements in local newspapers about a
s to cigarettes. 101 of 144 completed the two surveys. Pencil and paper
ts were recruited through advertisements in local newspapers about a
s to cigarettes. 59 of 67 completed the two surveys. In the US sample,
he research site on both occasions.
Table 2 Characteristics of the samples who completed both Pre and Post Fact Sheet surveys
Participant characteristics Aust n = 170 Sweden n=187 UK n=101 US n=59
Age (mean ± SD, years) 38.6 (11.1) 41.6 (11.9) 40 (12.6) 47.2 (9.7)
Sex (% males) 31.8 26.2 40.0 44.1
Education (% tertiary education) 38.2 29.4 19.8 20.3
Dependence (% heavy smokers#) 20 3.7 10.8 20.3
Ever use of NRT, % of total 70.0 64.2 60.4 49.2
Ever use of ST, % of total 7.7 40.1 11.0 10.2
NB: # heavy smokers means those who smoked more than 20 cigarettes per day and smoked first cigarette within 5 minutes of waking.
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countries, although this was not significant of itself in
the USA. Increases in knowledge were mainly among
those who read all or at least some of the Fact Sheet as
might be expected. Believing that NRT was far less
harmful than cigarettes increased overall, and although
the change was only significant in Australia, the increase
was similar in the smaller UK and USA samples, but
was smaller in Sweden. By contrast, believing that ST
was less harmful increased significantly in all countries,
although in no case to the level of the corresponding be-
lief about NRT. There was no change in the percentage
of respondents saying they were likely to use NRT for
their next quit attempt in Australia or Sweden, but there
were positive effects in both the UK and USA samples.
There were significant increases in interest in trying ST
in the three countries where subjects were asked about
interest in trying ST (this question was not asked in
Sweden as we assumed low levels of never trying).
We also looked to see if more accurate beliefs about
the relative harmfulness of the products were related to
beliefs about the mechanisms of harm. We found a
small but significant effect in Australia where the beliefs
became more highly inter-correlated (from -0.09 to
+0.18), however in the other three countries this effect
was not clear, although trends were mainly in the
expected direction. In all cases the relationship betweenTable 3 Reported levels of having read the Fact Sheet









Read Fact Sheet (% of total)
No 11.2 3.2 1.0 10.2
Yes, skim/some 51.8 34.2 9.9 33.9
Yes, all 37.1 62.6 89.1 55.9
Extent convinced (% of Read/skimmed only)
Totally 9.8 21.9 9.1 25
Largely 29.3 34.4 36.4 50
Uncertain 57.3 39.1 54.6 25
Not at all 3.7 4.7 0 0the knowledge score and beliefs about product harmful-
ness were low. Similarly the relationship between beliefs
in harmfulness and likelihood of use increased in
Australia (0.18 to 0.28 for NRT and 0.14 to 0.25 for ST),
although the increases were not significant.
Discussion
As hypothesized, exposure to the Fact Sheet improved
smokers’ knowledge levels about the relative harmful-
ness of ST/NRT compared to cigarettes and increased
interest in using both products as a substitute for their
cigarettes. However, the overall effect of exposure to the
Fact Sheet was modest, with many smokers remaining
unconvinced about the relative harms and the value of
switching from cigarettes to ST/NRT.
It is implausible that the improvements in knowledge
and beliefs found here could be due to secular trends.
The data was collected over a period of weeks or months
in three of the countries (it was done in a short interval
in Sweden), and there was no possibility of a common
extraneous event between the surveys that could plaus-
ibly produce the changes found. Further, findings from
the International Tobacco Control (ITC)-Four country
study (which covers 3 of the 4 countries studied here)
show smaller or no changes in some of these beliefs over
a period of years [26]. The low level of understanding
reflects a failure of public education, and in some cases
probably exacerbated by misleading statements from au-
thorities about relative harms [20].
This study has a number of limitations worth noting.
First, we relied on relatively small convenience samples
of smokers from each of the four countries. In two of
the countries, subjects recruited had some expectation
of being offered the opportunity to try some nicotine
products, and in a third (Australia), part of the sample
was told about such an opportunity between surveys.
However, the consistency of the results across the four
diverse samples strongly suggests that the Fact Sheet
improved knowledge wherever it was read. We would
also expect that those who chose to participate in the
study (especially returning for the second survey) are
probably, as a group more interested in using such
products than the general population of smokers, so
Table 4 Data comparison between Pre-test and Post-test, by country
Question Australia (n = 170) Sweden (n= 187) UK (n= 101) US (n = 59)
Survey 1 Survey 2 Survey 1 Survey 2 Survey 1 Survey2 Survey1 Survey 2
Intention to quit, (% of total) ***^ NS NS NS
Not thinking of quitting 31.2 26.6 46.0 39.0 73.1 63.3 72.9 69.5
Thinking of quitting, but not in the next month 16.5 17.3 42.8 44.4 9.9 9.9 22.0 20.3
Planning to quit in the next month 52.4 32.7 11.2 14.4 16.8 18.8 5.1 10.2
Already quit − 23.5 − 2.1 − 6.9 − 0
% correct perception of harmfulness of NRT vs
cigarettes (If answered ‘a lot less harmful’)
42.9 52.8*! 39.6 42.8NS 55.5 65.4NS 22.0 30.5NS
% correct perception of harmfulness of ST vs
cigarettes(If answered ‘a lot less harmful’)
7.7 35.8***! 14.4 28.3*** 21.8 53.5*** 6.8 27.1**
% Likely to use NRT (next try to quit) 56.3 52.5 NS! 70.8 55.4NS 64.4 75.3* 28.8 63.5***
% Likely to try ST (if available) 26.5 47.2***! 15.1 Not asked 50.5 79.2*** 28.8 45.8*
Knowledge score (0–5, mean) 2.06 2.47***# 2.4 2.8*** 2.2 2.5* 2.1 2.4 NS
Notes: *Significant at p< 0.05;**p< 0.01;***p< 0.001;NS = not significant . ^asymptotic symmetry tests; !McNemar tests; # Paired t test results for knowledge
scores.
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Sheet than a random sample of smokers. Thus we can-
not use this data to estimate likely population-level im-
pact of disseminating the information in a Fact Sheet
such as this.
Second, our findings concern a short period between
being exposed to the information and the test for
changes in outcomes. We do not know how much of the
increased knowledge will persist in the absence of re-
inforcing information. Evidence from education research
typically shows a decline in acquired knowledge with
time after a single exposure to new information, so it is
likely that there would need to be repeated exposures in
order for to the information to permanently alter beliefs,
intentions and to have any sustained influence on
tobacco use behaviours [18,19]. In this study we found
that the belief measures about the relative harmfulness
of ST/NRT were not strongly correlated with each other,
suggesting that beliefs about the harmfulness of different
tobacco products may not be strongly held and are thus
more susceptible to change than more strongly held
beliefs. Thus, even a relatively modest intervention such
as repeated exposure to facts about the relative dangers
of different nicotine containing products, coupled with
an explanation of why this is biologically plausible, might
over time prove to be effective in persuading smokers to
reduce their consumption of cigarettes, perhaps with
substitution of less dangerous nicotine delivery products.
It is also notable that the views of Swedish smokers were
very similar to those in the other countries, even though
the use of smokeless tobacco is widespread in Sweden.
Related to this, while we found consistent effects of
the Fact Sheet leading to increased interest in using
smokeless tobacco, we did not find a consistent effect
for nicotine replacement, which may be due to greaterexperience with NRT by smokers and greater awareness
of NRT products which have be widely promoted as an
alternative to cigarette smoking unlike smokeless
tobacco products, but note that where there was face to
face contact (the US sample) interest in NRT use
increased, but when all contact was via the internet (and
thus impersonal) we did not see such an effect.
Third, this study essentially relied upon a text only
pamphlet to communicate information to study subjects.
This mode of communication was selected since it mim-
icked what might be attached to cigarette packs. How-
ever, using more graphic and persuasive forms of
communication which would be repeated in multiple
communications channels would surely have produced
stronger effects.
Following provision of the Fact Sheet, smokers un-
interested in quitting in three of the samples (not
Sweden) were offered the possibility of trying some of
these products [28,29] and patterns of use and intentions
to use again were largely consistent with intentions as
expressed after receiving the Fact Sheet.
The results provide evidence that the provision of in-
formation in the form of, say, a cigarette pack onset/
insert, might be an effective means to educate smokers
about the relative harmfulness of alternative nicotine de-
livery products such as ST and NRT. Given the low levels
of knowledge that smokers had about harmfulness of dif-
ferent nicotine delivery products, it would seem to be in
the public interest to require such information to be
placed on cigarette packs and at the point of sale for
tobacco products to ensure that smokers are better in-
formed about the relative harmfulness of smoked and
unsmoked nicotine delivery products.
Improving community understanding is not something
that can occur in isolation from existing beliefs. We
Borland et al. Harm Reduction Journal 2012, 9:19 Page 6 of 7
http://www.harmreductionjournal.com/content/9/1/19suspect that beliefs about the harmfulness of tobacco,
and perhaps of negative assumptions about “chemicals”
may have created a context where there is an initial as-
sumption that anything labelled tobacco or which is a
chemical (e.g. nicotine) is likely to be harmful. In such a
context, it is clearly going to take more than reading one
Fact Sheet, however persuasive, to convince many that
their preconceptions are wrong. To proceed much fur-
ther, we need a jurisdiction to try to systematically edu-
cate its smokers using reliable information, presented
consistently through a concerted health education pro-
gram. Sweden would be the ideal country to do this as it
has a lot of ST users and use of NRT is also widespread.
(More countries could readily host such a campaign lim-
ited to NRT). When such an educational campaign hap-
pens, it will be important to carefully evaluate its effects
to see if it actually motivated increased movement away
from smoked tobacco products.
In conclusion it is possible to provide smokers with in-
formation that improves their understanding of the rela-
tive harms of nicotine delivery products, but this does
not necessarily translate into increased reported likeli-
hood of use. The current lack of knowledge would seem
to be largely due to the reluctance of governments to en-
sure that smokers are better informed about the
mechanisms by which their dependence on nicotine is
harming their health. This could be remedied either by
requiring or encouraging manufacturers to publicise this
information, and/or by governments doing so themselves
through public information campaigns.
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